STOCK ALARM
PRO
SA
PRO
News
Screener
Rankings
Themes
Alerts
More
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
BriaCell Therapeutics Corp.
BCTX
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Financials
Analysis
More
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$0
Gross Profit
$-148K
↓29%
Operating Income
$-38M
↑17%
Net Income
$-36M
↓457%
EBITDA
$-37M
↓453%
EPS Diluted
-86.3
Cost of Revenue
$148K
Gross Margin %
0.0%
R&D Expenses
$30M
SG&A Expenses
$6M
Operating Expenses
$38M
Operating Margin %
0.0%
Interest Expense
$51K
Income Before Tax
$-37M
Income Tax Expense
$0
Net Margin %
0.0%
EPS
-86.3
Shares Out (Diluted)
1.9M
Shares Out (Basic)
1.9M
Total Costs & Expenses
$38M
Interest Income
$166K
EBITDA Margin %
0.0%
Pre-Tax Margin %
0.0%
Other Income/Expenses
$900K
Revenue CAGR (5Y)
—
Margin Trend
stable
Free Cash Flow
($0.0B)
Profitability
Unprofitable
Metric
Jul 21
Jul 22
Jul 23
Jul 24
Jul 25
Revenue
0
0
0
0
0
Gross Profit
-0
-0
↑0.2%
-0
↓5.6%
-0
↓459.0%
-0
↓29.0%
Operating Income
-9
-19
↓118.4%
-31
↓60.8%
-46
↓45.7%
-38
↑17.2%
Net Income
-18
-34
↓93.6%
-27
↑20.1%
-7
↑76.0%
-36
↓457.4%
EBITDA
-18
-34
↓94.8%
-27
↑20.1%
-7
↑75.7%
-37
↓453.0%
EPS Diluted
-585.01
-330.38
↑43.5%
-261.86
↑20.7%
-59.69
↑77.2%
-86.25
↓44.5%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages